Appendix 4C – Q4 FY25 Quarterly Cash Flow Report
Appendix 4C – Q4 FY25 Quarterly Cash Flow Report GlobeNewswire July 30, 2025 Highlights Granted U.S. FDA Fast Track Designation for ATH434 to treat Multiple System Atrophy (MSA) Reported positive topline data from open-label Phase 2 clinical trial of ATH434 in MSA Presented additional analyses from the ATH434-201 trial demonstrating continued robust efficacy for the […]